Tmem119-EGFP and Tmem119-CreERT2 Transgenic Mice for Labeling and Manipulating Microglia
Microglia are specialized brain-resident macrophages with important functions in health and disease. To improve our understanding of these cells, the research community needs genetic tools to identify and control them in a manner that distinguishes them from closely related cell types. We have targe...
Main Authors: | , |
---|---|
Other Authors: | |
Format: | Article |
Language: | English |
Published: |
Society for Neuroscience
2020
|
Online Access: | https://hdl.handle.net/1721.1/126404 |
_version_ | 1826190774960652288 |
---|---|
author | Kaiser, Tobias Feng, Guoping |
author2 | McGovern Institute for Brain Research at MIT |
author_facet | McGovern Institute for Brain Research at MIT Kaiser, Tobias Feng, Guoping |
author_sort | Kaiser, Tobias |
collection | MIT |
description | Microglia are specialized brain-resident macrophages with important functions in health and disease. To improve our understanding of these cells, the research community needs genetic tools to identify and control them in a manner that distinguishes them from closely related cell types. We have targeted the recently discovered microglia-specific Tmem119 gene to generate knock-in mice expressing EGFP (JAX#031823) or CreERT2 (JAX#031820) for the identification and manipulation of microglia, respectively. Genetic characterization of the locus and qPCR-based analysis demonstrate correct positioning of the transgenes and intact expression of endogenous Tmem119 in the knock-in mouse models. Immunofluorescence analysis further shows that parenchymal microglia, but not other brain macrophages, are completely and faithfully labeled in the EGFP-line at different time points of development. Flow cytometry indicates highly selective expression of EGFP in CD11b+CD45lo microglia. Similarly, immunofluorescence and flow cytometry analyses using a Cre-dependent reporter mouse line demonstrate activity of CreERT2 primarily in microglia upon tamoxifen administration with the caveat of activity in leptomeningeal cells. Finally, flow cytometric analyses reveal absence of EGFP expression and minimal activity of CreERT2 in blood monocytes of the Tmem119-EGFP and Tmem119-CreERT2 lines, respectively. These new transgenic lines extend the microglia toolbox by providing the currently most specific genetic labeling and control over these cells in the myeloid compartment of mice. |
first_indexed | 2024-09-23T08:45:30Z |
format | Article |
id | mit-1721.1/126404 |
institution | Massachusetts Institute of Technology |
language | English |
last_indexed | 2024-09-23T08:45:30Z |
publishDate | 2020 |
publisher | Society for Neuroscience |
record_format | dspace |
spelling | mit-1721.1/1264042022-09-30T11:02:30Z Tmem119-EGFP and Tmem119-CreERT2 Transgenic Mice for Labeling and Manipulating Microglia Kaiser, Tobias Feng, Guoping McGovern Institute for Brain Research at MIT Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences Microglia are specialized brain-resident macrophages with important functions in health and disease. To improve our understanding of these cells, the research community needs genetic tools to identify and control them in a manner that distinguishes them from closely related cell types. We have targeted the recently discovered microglia-specific Tmem119 gene to generate knock-in mice expressing EGFP (JAX#031823) or CreERT2 (JAX#031820) for the identification and manipulation of microglia, respectively. Genetic characterization of the locus and qPCR-based analysis demonstrate correct positioning of the transgenes and intact expression of endogenous Tmem119 in the knock-in mouse models. Immunofluorescence analysis further shows that parenchymal microglia, but not other brain macrophages, are completely and faithfully labeled in the EGFP-line at different time points of development. Flow cytometry indicates highly selective expression of EGFP in CD11b+CD45lo microglia. Similarly, immunofluorescence and flow cytometry analyses using a Cre-dependent reporter mouse line demonstrate activity of CreERT2 primarily in microglia upon tamoxifen administration with the caveat of activity in leptomeningeal cells. Finally, flow cytometric analyses reveal absence of EGFP expression and minimal activity of CreERT2 in blood monocytes of the Tmem119-EGFP and Tmem119-CreERT2 lines, respectively. These new transgenic lines extend the microglia toolbox by providing the currently most specific genetic labeling and control over these cells in the myeloid compartment of mice. National Institute of Mental Health (Grant 5R01MH097104) National Cancer Institute (Grant P30-CA14051) 2020-07-27T20:16:49Z 2020-07-27T20:16:49Z 2019-07 2019-07 2019-10-01T12:50:28Z Article http://purl.org/eprint/type/JournalArticle 2373-2822 https://hdl.handle.net/1721.1/126404 Kaiser, Tobias and Guoping Feng. "Tmem119-EGFP and Tmem119-CreERT2 Transgenic Mice for Labeling and Manipulating Microglia." eNeuro 6, 4 (July 2019): 0448-18.2019 © 2019 Kaiser and Feng en http://dx.doi.org/10.1523/eneuro.0448-18.2019 eNeuro Creative Commons Attribution 4.0 International license https://creativecommons.org/licenses/by/4.0/ application/pdf Society for Neuroscience Society for Neurocience |
spellingShingle | Kaiser, Tobias Feng, Guoping Tmem119-EGFP and Tmem119-CreERT2 Transgenic Mice for Labeling and Manipulating Microglia |
title | Tmem119-EGFP and Tmem119-CreERT2 Transgenic Mice for Labeling and Manipulating Microglia |
title_full | Tmem119-EGFP and Tmem119-CreERT2 Transgenic Mice for Labeling and Manipulating Microglia |
title_fullStr | Tmem119-EGFP and Tmem119-CreERT2 Transgenic Mice for Labeling and Manipulating Microglia |
title_full_unstemmed | Tmem119-EGFP and Tmem119-CreERT2 Transgenic Mice for Labeling and Manipulating Microglia |
title_short | Tmem119-EGFP and Tmem119-CreERT2 Transgenic Mice for Labeling and Manipulating Microglia |
title_sort | tmem119 egfp and tmem119 creert2 transgenic mice for labeling and manipulating microglia |
url | https://hdl.handle.net/1721.1/126404 |
work_keys_str_mv | AT kaisertobias tmem119egfpandtmem119creert2transgenicmiceforlabelingandmanipulatingmicroglia AT fengguoping tmem119egfpandtmem119creert2transgenicmiceforlabelingandmanipulatingmicroglia |